Renal Tumor / / Jindong Chen, editor.

Summarizing a decade of scientific advance and therapeutic innovation, Renal Tumor offers all physicians treating kidney cancer, as well as researchers, updated information concerning the epidemiology, biology, and treatment of renal cell carcinoma. Contributors to this book are from all over the wo...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:Rijeka, Croatia : : IntechOpen,, [2013]
©2013
Year of Publication:2013
Language:English
Physical Description:1 online resource (218 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 00996nam a2200301 i 4500
001 993546085404498
005 20221017124518.0
006 m o d
007 cr |||||||||||
008 221017s2013 ci a ob 001 0 eng d
020 |a 953-51-7091-0 
035 |a (CKB)4970000000098547 
035 |a (NjHacI)994970000000098547 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/66415 
035 |a (EXLCZ)994970000000098547 
040 |a NjHacI  |b eng  |e rda  |c NjHacl 
041 0 |a eng 
050 4 |a RC255  |b .R463 2013 
082 0 4 |a 616.07  |2 23 
100 1 |a Chen, Jindong  |4 edt 
245 0 0 |a Renal Tumor /  |c Jindong Chen, editor. 
260 |b IntechOpen  |c 2013 
264 1 |a Rijeka, Croatia :  |b IntechOpen,  |c [2013] 
264 4 |c ©2013 
300 |a 1 online resource (218 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 |a Description based on: online resource; title from PDF information screen (InTech, viewed October 17, 2022). 
504 |a Includes bibliographical references and index. 
520 |a Summarizing a decade of scientific advance and therapeutic innovation, Renal Tumor offers all physicians treating kidney cancer, as well as researchers, updated information concerning the epidemiology, biology, and treatment of renal cell carcinoma. Contributors to this book are from all over the world and are experts in their individual fields. They have provided reviews about current knowledge in the management of both localized and metastatic renal cell carcinoma, as well as the latest developments in molecular genetics, imaging, and immune dysfunction associated with the diseases. Further special attention is paid to the biology of selected target molecules and various agents that inhibit these targets, including full chapters devoted to pharmaceutical drugs that selectively inhibit receptor tyrosine kinases, such as sunitinib and axitinib. Readers such as urological physicians, researchers, and kidney cancer patients are potential beneficiaries of this book. 
546 |a English 
650 0 |a Tumors  |x Diagnosis. 
653 |a Oncology 
776 |z 953-51-0981-2 
700 1 |a Chen, Jindong,  |e editor. 
906 |a BOOK 
ADM |b 2023-02-22 04:02:42 Europe/Vienna  |f system  |c marc21  |a 2019-04-13 22:04:18 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338108180004498&Force_direct=true  |Z 5338108180004498  |b Available  |8 5338108180004498